Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,60%
1 062,40
+6,32
+0,60%
—1 056,081 055,451 067,221 044,14——
SIXC
Communications
SIXC
Communications
SIXC
-0,03%
606,74
-0,16
-0,03%
—606,90606,90610,73601,25——
SIXE
Energy
SIXE
Energy
SIXE
-1,08%
1 238,21
-13,50
-1,08%
—1 251,711 264,021 267,841 229,38——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,12%
1 718,61
-2,03
-0,12%
—1 720,641 717,521 726,381 702,65——
SIXM
Financials
SIXM
Financials
SIXM
+0,21%
637,37
+1,36
+0,21%
—636,01635,43638,14630,76——
SIXR
Staples
SIXR
Staples
SIXR
-0,96%
853,59
-8,29
-0,96%
—861,88854,93854,93841,82——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,33
+0,25
+0,11%
—218,08218,08218,46215,77——
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 594,81
+27,84
+0,78%
—3 566,973 549,543 603,173 543,40——
SIXU
Utilities
SIXU
Utilities
SIXU
+1,03%
908,54
+9,27
+1,03%
—899,27900,59908,91897,62——
SIXV
Health care
SIXV
Health care
SIXV
+0,64%
1 495,00
+9,53
+0,64%
—1 485,471 483,471 496,661 472,99——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,64%
2 398,31
+15,25
+0,64%
—2 383,062 381,252 408,622 360,53——
AFT:NZE
AFT Pharmaceuticals Ltd
NZ$3,88
+2,11%
(+0,080) 1D
22 Mei, 17:00:25 GMT+12  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for AFT...
Open
NZ$3,73
High
NZ$3,89
Low
NZ$3,73
Mkt. cap
370,18 m
Avg. vol.
15,65 k
Volume
70,48 k
Dividend
0,31%
Quarterly dividend
NZ$0,00
Ex-dividend date
18 Jun. 2025
P/E ratio
23,32
52-wk high
NZ$3,89
52-wk low
NZ$2,51
EPS
NZ$0,17
Shares outstanding
104,87 m
No. of employees
119
News stories
From sources across the web
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees119
Founded1997
Headquarters-
SectorPharmaceutical industry
Websiteaftpharm.com
Previous reportsAll values in NZD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NZD
Des. 2024
Mrt. 2025
Jun. 2025
Sep. 2025
Revenue
60,65 m
60,65 m
57,47 m
57,47 m
Cost of goods sold
32,90 m
32,90 m
32,63 m
32,63 m
Cost of revenue
32,90 m
32,90 m
32,63 m
32,63 m
Research and development expenses
2,23 m
2,23 m
3,06 m
3,06 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,17 m
16,17 m
19,10 m
19,10 m
Operating expense
18,03 m
18,03 m
22,48 m
22,48 m
Total operating expenses
50,93 m
50,93 m
55,10 m
55,10 m
Operating income
9,73 m
9,73 m
2,37 m
2,37 m
Other non operating income
79,00 k
79,00 k
462,50 k
462,50 k
EBT including unusual items
9,44 m
9,44 m
2,22 m
2,22 m
EBT excluding unusual items
9,44 m
9,44 m
2,22 m
2,22 m
Income tax expense
2,51 m
2,51 m
856,50 k
856,50 k
Effective tax rate
26,58%
26,58%
38,61%
38,61%
Other operating expenses
-376,50 k
-376,50 k
318,00 k
318,00 k
Net income
7,07 m
7,07 m
1,65 m
1,65 m
Net profit margin
11,66%
11,66%
2,87%
2,87%
Earnings per share
-
-
-
-
Interest and investment income
1,50 k
1,50 k
2,50 k
2,50 k
Interest expense
-732,00 k
-732,00 k
-615,00 k
-615,00 k
Net interest expenses
-730,50 k
-730,50 k
-612,50 k
-612,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
10,70 m
10,70 m
3,07 m
3,07 m
Gain or loss from assets sale
115,50 k
115,50 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer